Egalet received grant from InnoBooster to develop a novel application of Guardian™
Egalet announced the company was awarded a grant from InnoBooster to develop a novel oral delivery system using a new application of Egalet's Guardian Technology to develop products in therapeutic areas outside of pain. InnoBooster is a fund under the Danish Growth Fund. November 20, 2017